Phoenix sylvestris Roxb pollen allergy: A 2-year randomized controlled trial and follow-up study of immunotherapy in patients with seasonal allergy in an agricultural area of West Bengal, India

Journal of Investigational Allergology and Clinical Immunology

Volumn 16, Issue 6, 2006, Pages 377-384

  Chakraborty, P ^a   Roy, I ^b   Chatterjee, S ^c   Chanda, S ^c   Gupta Bharracharya, Swati ^d  

^a Sree Chaitanya College   (India)

^b INSTITUTE OF CHILD HEALTH   (India)

^c Natural Resources Data Management System India   (India)

^d BOSE INSTITUTE   (India)

Author keywords

Double blind placebo controlled trial; Immunotherapy; Phoenix sylvestris pollen; Seasonal rhinitis

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; PLACEBO; POLLEN EXTRACT;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HAY FEVER; HUMAN; IMMUNOTHERAPY; MALE; PHOENIX SYLVESTRIS; POLLEN ALLERGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SCORING SYSTEM; SYMPTOM; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; ANGIOSPERMS; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULINS; INDIA; MALE; MIDDLE AGED; PLANT EXTRACTS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX;

EID: 33845623199     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Chakraborty P, Gupta-Bhattacharya S, Chakraborty C, Lacey J, Chanda S. Airborne allergenic pollen grains on a farm in West Bengal, India. Grana. 1998;37:53-7.
2. Chakraborty P, Chowdhury I, Gupta Bhattacharya S, Gupta S, Sengupta DN, Chanda S. Clinicoimmunologic studies on Phoenix sylvestris Roxb. Pollen: an aeroallergen from Calcutta, India. Allergy. 1999;54:985-9.
3. Bosquet J, Lockey R, Malling H-J (Eds.) WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy. 1998;53(Suppl 44):1-42.
4. Walker SM, Varney VA, Gaga M, Jacobson MR, Durham SR. Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study. Allergy.1995;50:405-13.
5. Arvidson MB, Lowhagen O, Rak S. Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy. J Allergy Clin Immunol. 2002; 109:777-83.
6. Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, Koivikko A, Koller DY, Niggermann B, Norberg LA, Urbanek R, Valovirta E, Wahn U. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study). J Allergy Clin Immunol. 2002;109:251-6.
7. Frew AJ. Immunotherapy of allegic disease. J Allergy Clin Immunol. 2003;111:s712-19.
8. The British Aerobiology Federation. A guide to trapping and counting. Kimberley Clark Ltd., UK. 1995.
9. Dreborg S, Frew AJ, Eds. Allergen standardization and skin tests. Allergy. 1993;48(Suppl 48):49-82.
10. Stytis DP, Stobo JD, Fudenberg H,Wells JV. Basic and clinical immunology. Singapore: Lange Medical Publishers. Maruzen Asia (Pvt) Ltd; 1982.
11. American Thoracic Society. Standardization of spirometry - 1987 update. Am Rev Resp Dis. 1987;136:1285-98.
12. Malling HJ, Weeke B. Eds. EACI position paper. Immunotherapy. Allergy. 1995;50(Suppl 14):7-15.
13. Nelson HS. The use of standardized extracts in allergen immunotherapy. J Allergy Clin Immunol. 2000;106: 41-5.
14. Karmakar PR, Das A, Chatterjee BP. Placebo-controlled immunotherapy with Cocos nucifera pollen extract. Int Arch Allergy Immunol. 1994;103:194-201.
15. Balda BR, Wolf H, Baumgarten C, Klimek L, Rasp G, Kunkel G, Muller S, Mann W, Hauswald B, Heppt W, Przybilla B, Amon U, Bischoff R, Becher G, Hummel S, Frosch PJ, Rustemeyer T, Jager L, Brehler R, Luger T, Schnitker J. Tree pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized extracts. Allergy. 1998;53:740-8.
16. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT. Long-term clinical efficacy of grass pollen immunotherapy. N Engl J Med. 1999;341:468-75.
17. Pajno GB, Barberio G, De Luca F, Morabito L, Farmiani S. Prevention of new sensitization in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy. 2001;31:1392-7.
18. Dinakar C, Portnoy JM. Allergen immunotherapy in the prevention of asthma. Curr Opin Allergy Clin Immunol. 2004;4:131-6.
19. Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S, Klotz F, Ebner H, Kraft D, Scheiner O. Immunological changes during specific IT of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from Th2 to Th1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy 1997;27:1007-15.
20. Greenberger PA. Immunotherapy update: mechanism of action. Allergy Asthma Proc. 2002; 23:373-6.
21. Gehlher K, Schlaak M, Becker W, Bufe A. Monitoring allergenic immunotherapy of pollen allergic patients: the ratio of allergen specific IgG4 to IgG1 correlates with clinical outcome. Clin Exp Allergy. 1999; 29:497-506.
22. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol. 2003;33:1205-14.
23. Hardy CL, Rolland JM, O'Hehir RE. Blocking antibodies in immunotherapy: the Yin and Yang. Clin Exp Allergy. 2004;34:510-12.
24. Nouri-Aria KT, Wachloz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, Staple SQ, Aalberse SQ, Till SJ, Durham SR. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG4 activity. J Immunol. 2004;172:3252-9.
25. Ewan PW, Deighton J, Wilson AB, Lachmann PJ. Venom specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings. Clin Exp Allergy. 1993;23:647-60.
26. Aalberse RC, F. van Milliga KY, Tan. Stapel SO. Allergen-specific IgG4 in atopic disease. Allergy. 1993;48:559.
27. Li JT, Lockey RF, Bernstein IL, Portnoy JM, Nicklas RA. Allergen immunotherapy: a practice parameter. Ann Allergy Asthma Immunol. 2003;90:1-36.
28. Van Metre TE Jr, Adkinson NF Jr, Lichtenstein LM, Mardiney MR Jr, Norman PS Jr, Rosenberg GL, Sobotka AK, Valentine MD. A controlled study on the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol .1980;65:288-97.